Professional Documents
Culture Documents
Pharmacology of Amlodipine
Pharmacology of Amlodipine
Amlodipine
MOA
Dihydropyridine calcium channel
blocker
Blocks L-type calcium channels and
inhibits inward passage of calcium
ions through these channels
Binds to a site on 1 subunit
Pharmacokinetics
Oral Bioavailability: 65-90%
Half-life: 30-50 hours
Adverse Effects
Headache
Flushing
Peripheral oedema
Palpitations
Interactions
Hypotension may be exacerbated if
CCB are administered with other BP
lowering drugs (e.g. beta blockers)